Compare TASK & PRME Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | TASK | PRME |
|---|---|---|
| Founded | 2008 | 2019 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Retail: Computer Software & Peripheral Equipment | Medicinal Chemicals and Botanical Products |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 585.9M | 666.1M |
| IPO Year | 2021 | 2022 |
| Metric | TASK | PRME |
|---|---|---|
| Price | $6.31 | $3.53 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 5 | 6 |
| Target Price | ★ $14.70 | $7.56 |
| AVG Volume (30 Days) | 537.6K | ★ 1.7M |
| Earning Date | 05-06-2026 | 05-08-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 120.00 | 18.18 |
| EPS | ★ 1.10 | N/A |
| Revenue | N/A | ★ $4,632,000.00 |
| Revenue This Year | $5.95 | $7.06 |
| Revenue Next Year | $6.46 | $47.01 |
| P/E Ratio | $5.78 | ★ N/A |
| Revenue Growth | N/A | ★ 55.28 |
| 52 Week Low | $6.20 | $1.11 |
| 52 Week High | $18.39 | $6.94 |
| Indicator | TASK | PRME |
|---|---|---|
| Relative Strength Index (RSI) | 32.48 | 45.33 |
| Support Level | $6.30 | $3.17 |
| Resistance Level | $7.54 | $3.94 |
| Average True Range (ATR) | 0.32 | 0.22 |
| MACD | 0.06 | -0.00 |
| Stochastic Oscillator | 3.12 | 36.12 |
TaskUs Inc provides outsourced digital services. Its service offerings include Digital Customer Experience consists of omnichannel customer care services, delivered through digital (non-voice) channels, also including learning experience and sales and customer acquisition services; Trust & Safety consists of monitoring, reviewing and managing user and advertiser-generated content on online platforms to ensure it complies with community guidelines, legal regulations and platform specific policies; and AI Services consists of large language model support and high-quality data labeling services, annotation, context relevance and transcription services performed for the purpose of training and tuning machine learning algorithms, enabling them to develop cutting-edge AI systems.
Prime Medicine Inc is a biotechnology company committed to delivering genetic therapies to address diseases by deploying gene editing technology, Prime Editing. The Prime Editing technology is a next-generation technology that can search and replace to restore normal genetic function in the genome and can treat a wide spectrum of diseases with high unmet medical needs and efficient and broad gene editing technology.